Drug Eluting Stent    Long-Term Clinical Outcomes after Sirolimus-Eluting Stent Implantation for Treatment of Restenosis within Bare-Metal Versus Drug-Eluting Stents Catheter Cardiovasc Interv (2008) 71;594-8 C. Whan Lee, et al. Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients with Unstable Angina Pectoris (a Sirius Substudy) Am J Cardiol (2007) 99;1044-50 G. Weisz, et al. Increased Late Mortality after Sirolimus-Eluting Stents Versus Bare-Metal Stents in Diseased Saphenous Vein Grafts: Results from the Randomized Delayed Rrisc Trial J Am Coll Cardiol (2007) 50;261-7 P. Vermeersch, et al. Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization with Sirolimus-Eluting Stents: A Subanalysis of the Arts Ii Trial J Am Coll Cardiol (2007) 49;431-41 M. Valgimigli, et al. Two-Year Clinical Follow-up after Sirolimus-Eluting Versus Bare-Metal Stent Implantation Assisted by Systematic Glycoprotein Iib/Iiia Inhibitor Infusion in Patients with Myocardial Infarction: Results from the Strategy Study J Am Coll Cardiol (2007) 50;138-45 M. Valgimigli, et al. Polymer-Based, Paclitaxel-Eluting Taxus Liberte Stent in De Novo Lesions: The Pivotal Taxus Atlas Trial J Am Coll Cardiol (2007) 49;1676-83 M. A. Turco, et al. Two-Year Serial Coronary Angiographic and Intravascular Ultrasound Analysis of in-Stent Angiographic Late Lumen Loss and Ultrasonic Neointimal Volume from the Taxus Ii Trial Am J Cardiol (2007) 99;607-15 K. Tsuchida, et al. Stent Thrombosis after Sirolimus- and Paclitaxel-Eluting Stent Implantation in Daily Clinical Practice: Analysis of a Single Center Registry Catheter Cardiovasc Interv (2007) 70;415-21 D. Trabattoni, et al. Impact of Vessel Size on Outcome after Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the Sirtax Trial J Am Coll Cardiol (2007) 50;1123-31 M. Togni, et al. Comparison of in Vivo Acute Stent Recoil between the Bioabsorbable Everolimus-Eluting Coronary Stent and the Everolimus-Eluting Cobalt Chromium Coronary Stent: Insights from the Absorb and Spirit Trials Catheter Cardiovasc Interv (2007) 70;515-23 S. Tanimoto, et al. Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction after Paclitaxel-Eluting and Bare Metal Stent Implantation Circulation (2007) 115;2842-7 G. W. Stone, et al. Comparative Clinical Outcomes of Paclitaxel- and Sirolimus-Eluting Stents: Results from a Large Prospective Multicenter Registry--Stent Group J Am Coll Cardiol (2007) 50;1214-22 C. A. Simonton, et al. Angiographic Stent Thrombosis after Routine Use of Drug-Eluting Stents in St-Segment Elevation Myocardial Infarction: The Importance of Thrombus Burden J Am Coll Cardiol (2007) 50;573-83 G. Sianos, et al. Neointimal Progression and Luminal Narrowing in Sirolimus-Eluting Stent Treatment for Bare Metal in-Stent Restenosis: A Quantitative Intravascular Ultrasound Analysis Am Heart J (2007) 154;361-5 R. Sakurai, et al. Comparison between Sirolimus- and Paclitaxel-Eluting Stents in Complex Patient and Lesions Subsets Catheter Cardiovasc Interv (2007) 70;167-72 P. Roy, et al. Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents Am J Cardiol (2007) 100;965-9 P. Roy, et al. Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery: An Intravascular Ultrasound Study J Am Coll Cardiol (2007) 49;539-46 A. S. Petronio, et al. The Impact of Renal Function on the Long-Term Clinical Course of Patients Who Underwent Percutaneous Coronary Intervention Catheter Cardiovasc Interv (2007) 69;189-97 M. I. Papafaklis, et al. Randomized Comparative Trial of a Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Sirolimus-Eluting Stent for Coronary Revascularization Catheter Cardiovasc Interv (2007) 69;790-8 P. Ortolani, et al. Sirolimus-Eluting Stent Implantation Aggravates Endothelial Vasomotor Dysfunction in the Infarct-Related Coronary Artery in Patients with Acute Myocardial Infarction J Am Coll Cardiol (2007) 50;1305-9 J. E. Obata, et al. Efficacy of Reduced-Dose Sirolimus-Eluting Stents in the Human Coronary Artery: Serial Ivus Analysis of Neointimal Hyperplasia and Luminal Dimension Catheter Cardiovasc Interv (2007) 70;946-51 M. Nakamura, et al. Comparison of Myocardial Perfusion by Distal Protection before and after Primary Stenting for Acute Myocardial Infarction: Angiographic and Clinical Results of a Randomized Controlled Trial Catheter Cardiovasc Interv (2007) 70;677-82 T. Muramatsu, et al. The Sirius-Direct Trial: A Multi-Center Study of Direct Stenting Using the Sirolimus-Eluting Stent in Patients with De Novo Native Coronary Artery Lesions Catheter Cardiovasc Interv (2007) 70;505-12 J. W. Moses, et al. Long-Term Clinical Outcomes with Sirolimus-Eluting Coronary Stents: Five-Year Results of the Ravel Trial J Am Coll Cardiol (2007) 50;1299-304 M. C. Morice, et al. Clinical Impact of in-Stent Late Loss after Drug-Eluting Coronary Stent Implantation Eur Heart J (2007) 28;1583-91 R. Moreno, et al. Long-Term Outcomes after Management of Restenosis or Thrombosis of Drug-Eluting Stents J Am Coll Cardiol (2007) 49;181-4 G. J. Mishkel, et al. Randomized Trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (Sesami) J Am Coll Cardiol (2007) 49;1924-30 M. Menichelli, et al. Coronary Collateral Function Long after Drug-Eluting Stent Implantation J Am Coll Cardiol (2007) 49;15-20 P. Meier, et al. Long-Term Safety and Efficacy of Drug-Eluting Stents: Two-Year Results of the Real (Registro Angioplastiche Dell'emilia Romagna) Multicenter Registry Circulation (2007) 115;3181-8 A. Marzocchi, et al. Target Lesion Revascularisation in Patients Treated with a Sirolimus-Eluting or Paclitaxel-Eluting Stent Heart (2007) 93;694-7 M. Maeng, et al. Frequency of Stent Fracture as a Cause of Coronary Restenosis after Sirolimus-Eluting Stent Implantation Am J Cardiol (2007) 100;627-30 S. H. Lee, et al. Stent Fracture Associated with Drug-Eluting Stents: Clinical Characteristics and Implications Catheter Cardiovasc Interv (2007) 69;387-94 M. S. Lee, et al. Incidence and Predictors of Recurrent Restenosis Following Implantation of Drug-Eluting Stents for in-Stent Restenosis Catheter Cardiovasc Interv (2007) 69;104-8 C. W. Lee, et al. Late Vascular Response at the Edges of Sirolimus Analogous-Eluting Stents in Diabetic Patients: An Intravascular Ultrasound Study Catheter Cardiovasc Interv (2007) 70;498-503 L. I. Lasave, et al. Comparison of Drug-Eluting Stents with Bare Metal Stents in Unselected Patients with Acute Myocardial Infarction Catheter Cardiovasc Interv (2007) 70;1-8 L. I. Kupferwasser, et al. Effect of Celecoxib on Restenosis after Coronary Angioplasty with a Taxus Stent (Corea-Taxus Trial): An Open-Label Randomised Controlled Study Lancet (2007) 370;567-74 B. K. Koo, et al. Increased Incidence of Stent Thrombosis in Patients with Cocaine Use Catheter Cardiovasc Interv (2007) 69;955-8 G. Karlsson, et al. Transition from Bare Metal to Drug Eluting Stenting in Contemporary Us Practice: Effect on Incidence and Predictors of Clinically Driven Target Lesion Revascularization Catheter Cardiovasc Interv (2007) 70;175-83 M. Jonas, et al. Clinical Outcomes of Dexamethasone-Eluting Stent Implantation in St-Elevation Acute Myocardial Infarction Catheter Cardiovasc Interv (2007) 70;492-7 S. Jimenez-Valero, et al. Does Creatine Kinase-Mb (Ck-Mb) Isoenzyme Elevation Following Percutaneous Coronary Intervention with Drug-Eluting Stents Impact Late Clinical Outcome? Catheter Cardiovasc Interv (2007) 70;826-31 A. Javaid, et al. Late Target Lesion Revascularization after Implantation of Sirolimus-Eluting Stent Catheter Cardiovasc Interv (2007) M. K. Hong, et al. Does Incomplete Endothelializaion Deteriorate the Long Term Safety of Drug Eluting Stents? Catheter Cardiovasc Interv (2007) 70;1052 K. Hasegawa and H. Tamai A Comparison of Mortality, Myocardial Infarction, and Repeated Revascularization for Sirolimus-Eluting and Paclitaxel-Eluting Coronary Stents Am Heart J (2007) 154;545-53 E. L. Hannan, et al. Estrogen-Eluting Stent Implantation Inhibits Neointimal Formation and Extracellular Signal-Regulated Kinase Activation Catheter Cardiovasc Interv (2007) 70;647-53 Y. Han, et al A New Intra-Arterial Delivery Platform for Pro-Arteriogenic Compounds to Stimulate Collateral Artery Growth Via Transforming Growth Factor-Beta1 Release J Am Coll Cardiol (2007) 50;351-8 S. Grundmann, et al. Effectiveness and Safety of the Sirolimus-Eluting Stents Coated with Bioabsorbable Polymer Coating in Human Coronary Arteries Catheter Cardiovasc Interv (2007) 69;198-202 J. Ge, et al. The Impact of Oral Antiplatelet Responsiveness on the Long-Term Prognosis after Coronary Stenting Am Heart J (2007) 154;676-81 S. G. Foussas, et al. Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization Circulation (2007) 115;2435-41 A. V. Finn, et al. Impact of Bivalirudin on Outcomes after Percutaneous Coronary Revascularization with Drug-Eluting Stents Am Heart J (2007) 154;695-701 D. N. Feldman, et al. Incidence, Timing, and Correlates of Stent Thrombosis with the Polymeric Paclitaxel Drug-Eluting Stent: A Taxus Ii, Iv, V, and Vi Meta-Analysis of 3,445 Patients Followed for up to 3 Years J Am Coll Cardiol (2007) 49;1043-51 S. G. Ellis, et al. Outcomes of Stent Thrombosis and Restenosis During Extended Follow-up of Patients Treated with Bare-Metal Coronary Stents Circulation (2007) 116;2391-8 B. Doyle, et al. Effectiveness of Drug-Eluting Stents in Patients with Bare-Metal in-Stent Restenosis: Meta-Analysis of Randomized Trials J Am Coll Cardiol (2007) 49;616-23 A. Dibra, et al. Sirolimus-Eluting Stents Compared with Standard Stents in the Treatment of Patients with Primary Angioplasty Am Heart J (2007) 154;164 e1-6 L. S. Diaz de la Llera, et al. Intravascular Ultrasound Assessment of Drug-Eluting Stent Expansion Am Heart J (2007) 153;297-303 J. de Ribamar Costa, Jr., et al. Usefulness of Multislice Computed Tomographic Coronary Angiography to Identify Patients with Abnormal Myocardial Perfusion Stress in Whom Diagnostic Catheterization May Be Safely Avoided Am J Cardiol (2007) 100;1605-8 S. C. Danciu, et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions Circulation (2007) 115;2344-51 D. E. Cutlip, et al. Relocation of Minimal Luminal Diameter after Bare Metal and Drug-Eluting Stent Implantation: Incidence and Impact on Angiographic Late Loss Catheter Cardiovasc Interv (2007) 69;181-8 M. A. Costa, et al. Repeated Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis: The Same or a Different Stent Am Heart J (2007) 153;354-9 J. Cosgrave, et al. Late Restenosis Following Sirolimus-Eluting Stent Implantation Am J Cardiol (2007) 100;41-4 J. Cosgrave, et al. Concurrent Implantation of Sirolimus- and Paclitaxel-Eluting Stents in the Same Vessel Catheter Cardiovasc Interv (2007) 69;109-14 S. J. Corbett, et al. Incomplete Stent Apposition and Very Late Stent Thrombosis after Drug-Eluting Stent Implantation Circulation (2007) 115;2426-34 S. Cook, et al. Use of Endothelial Progenitor Cell Capture Stent (Genous Bio-Engineered R Stent) During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Intermediate- to Long-Term Clinical Follow-Up Am Heart J (2008) 155;128-32 M. Co, et al. Favorable Long-Term Outcome after Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry Circulation (2007) 116;158-62 A. Chieffo, et al. Enhanced Inflammatory Response to Coronary Stenting Marks the Development of Clinically Relevant Restenosis Catheter Cardiovasc Interv (2007) 69;500-7 A. M. Caixeta, et al. Impact of Platelet Reactivity after Clopidogrel Administration on Drug-Eluting Stent Thrombosis J Am Coll Cardiol (2007) 49;2312-7 P. Buonamici, et al. Three-Year Follow-up of the First Prospective Randomized Comparison between Paclitaxel and Sirolimus Stents: The Taxi-Late Trial Catheter Cardiovasc Interv (2007) 70;163-6 A. Berger, et al. Outcomes and Complications Associated with Off-Label and Untested Use of Drug-Eluting Stents JAMA (2007) 297;1992-2000 N. Beohar, et al. One-Year Results of the Scorpius Study: A German Multicenter Investigation on the Effectiveness of Sirolimus-Eluting Stents in Diabetic Patients J Am Coll Cardiol (2007) 50;1627-34 D. Baumgart, et al. Serial Angioscopic Evidence of Incomplete Neointimal Coverage after Sirolimus-Eluting Stent Implantation: Comparison with Bare-Metal Stents Circulation (2007) 116;910-6 M. Awata, et al. Incidence and Clinical Impact of Coronary Stent Fracture after Sirolimus-Eluting Stent Implantation Catheter Cardiovasc Interv (2007) 69;380-6 J. Aoki, et al. Intravascular Ultrasound Findings During Episodes of Drug-Eluting Stent Thrombosis J Am Coll Cardiol (2007) 50;2095-7 F. Alfonso, et al. Incidence and Predictors of Drug-Eluting Stent Thrombosis During and after Discontinuation of Thienopyridine Treatment Circulation (2007) 116;745-54 F. Airoldi, et al. Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent? Results of the Isar-Peace Randomized Trial J Am Coll Cardiol (2007) 49;1265-71 T. Adriaenssens, et al. Clinical and Angiographic Results of Percutaneous Coronary Revascularization Using a Trilayer Stainless Steel-Tantalum-Stainless Steel Phosphorylcholine-Coated Stent: The Trimaxx Trial Catheter Cardiovasc Interv (2007) 70;914-9 A. Abizaid, et al. Randomized, Double-Blind, Multicenter Study of the Polymer-Based 17-Beta Estradiol-Eluting Stent for Treatment of Native Coronary Artery Lesions: Six-Month Results of the Ethos I Trial Catheter Cardiovasc Interv (2007) 70;654-60 A. Abizaid, et al. Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings from the National Heart, Lung, and Blood Institute Dynamic Registry J Am Coll Cardiol (2007) 50;2029-36 J. D. Abbott, et al.